Actelion may acquire Tetraphase pharmaceuticals - MarketLine Financial Deals

Actelion may acquire Tetraphase pharmaceuticals

Actelion may acquire Tetraphase pharmaceuticals - MarketLine Financial Deals
Actelion may acquire Tetraphase pharmaceuticals
Published Nov 22, 2014
2 pages — Published Nov 22, 2014
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

According to Bloomberg, Actelion, Ltd. is a potential bidder for Tetraphase pharmaceuticals, Inc.

  
Source:
Document ID
MA151705_141126
Country
Country
Ticker
ATLN=CH
Ticker
Company
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Actelion may acquire Tetraphase pharmaceuticals" Nov 22, 2014. Alacra Store. Dec 09, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Actelion-may-acquire-Tetraphase-pharmaceuticals-2052-107159>
  
APA:
MarketLine Financial Deals. (2014). Actelion may acquire Tetraphase pharmaceuticals Nov 22, 2014. New York, NY: Alacra Store. Retrieved Dec 09, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Actelion-may-acquire-Tetraphase-pharmaceuticals-2052-107159>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.